Fundies.
English

Segment disclosures

Company overview

Bioventus Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 57 retained observations 16 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · International Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=bvs:InternationalSegmentMember
PeriodValueUnitFiledEvidence
2026-03-29 – 2026-06-2718743000 USD20260805Open filing evidence
2026-01-01 – 2026-06-2734387000 USD20260805Open filing evidence
2026-01-01 – 2026-03-2815644000 USD20260506Open filing evidence
2025-01-01 – 2025-12-3165990000 USD20260305Open filing evidence
2025-06-29 – 2025-09-2715337000 USD20251104Open filing evidence
2025-01-01 – 2025-09-2747578000 USD20251104Open filing evidence
2025-03-30 – 2025-06-2818885000 USD20260805Open filing evidence
2025-01-01 – 2025-06-2832241000 USD20260805Open filing evidence
2025-01-01 – 2025-03-2913356000 USD20260506Open filing evidence
2024-01-01 – 2024-12-3166471000 USD20260305Open filing evidence
2024-06-30 – 2024-09-2816055000 USD20251104Open filing evidence
2024-01-01 – 2024-09-2848039000 USD20251104Open filing evidence
2024-03-31 – 2024-06-2916808000 USD20250806Open filing evidence
2024-01-01 – 2024-06-2931984000 USD20250806Open filing evidence
2024-01-01 – 2024-03-3015176000 USD20250506Open filing evidence
2023-01-01 – 2023-12-3162485000 USD20260305Open filing evidence
2023-07-02 – 2023-09-3014567000 USD20241105Open filing evidence
2023-01-01 – 2023-09-3045870000 USD20241105Open filing evidence
2023-01-01 – 2023-04-0115081000 USD20240507Open filing evidence
2022-01-01 – 2022-12-3156866000 USD20250311Open filing evidence

Operating Segments · US Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=bvs:USSegmentMember
PeriodValueUnitFiledEvidence
2026-03-29 – 2026-06-27134465000 USD20260805Open filing evidence
2026-01-01 – 2026-06-27250910000 USD20260805Open filing evidence
2026-01-01 – 2026-03-28116445000 USD20260506Open filing evidence
2025-01-01 – 2025-12-31502097000 USD20260305Open filing evidence
2025-06-29 – 2025-09-27123314000 USD20251104Open filing evidence
2025-01-01 – 2025-09-27362609000 USD20251104Open filing evidence
2025-03-30 – 2025-06-28128775000 USD20260805Open filing evidence
2025-01-01 – 2025-06-28239295000 USD20260805Open filing evidence
2025-01-01 – 2025-03-29110520000 USD20260506Open filing evidence
2024-01-01 – 2024-12-31506809000 USD20260305Open filing evidence
2024-06-30 – 2024-09-28122909000 USD20251104Open filing evidence
2024-01-01 – 2024-09-28371599000 USD20251104Open filing evidence
2024-03-31 – 2024-06-29134409000 USD20250806Open filing evidence
2024-01-01 – 2024-06-29248690000 USD20250806Open filing evidence
2024-01-01 – 2024-03-30114281000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31449860000 USD20260305Open filing evidence
2023-07-02 – 2023-09-30106227000 USD20241105Open filing evidence
2023-01-01 – 2023-09-30331052000 USD20241105Open filing evidence
2022-01-01 – 2022-12-31455251000 USD20250311Open filing evidence

International Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bvs:InternationalSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-06-28 – 2026-09-2617846000 USD20261102Open filing evidence
2026-01-01 – 2026-09-2652233000 USD20261102Open filing evidence
2025-06-29 – 2025-09-2715337000 USD20261102Open filing evidence
2025-01-01 – 2025-09-2747578000 USD20261102Open filing evidence
2024-03-31 – 2024-06-2916808000 USD20240806Open filing evidence
2024-01-01 – 2024-06-2931984000 USD20240806Open filing evidence
2023-04-02 – 2023-07-0116222000 USD20240806Open filing evidence
2023-01-01 – 2023-07-0131303000 USD20240806Open filing evidence

US Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bvs:USSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-06-28 – 2026-09-26124596000 USD20261102Open filing evidence
2026-01-01 – 2026-09-26375506000 USD20261102Open filing evidence
2025-06-29 – 2025-09-27123314000 USD20261102Open filing evidence
2025-01-01 – 2025-09-27362609000 USD20261102Open filing evidence
2024-03-31 – 2024-06-29134409000 USD20240806Open filing evidence
2024-01-01 – 2024-06-29248690000 USD20240806Open filing evidence
2024-01-01 – 2024-03-30114281000 USD20240507Open filing evidence
2023-04-02 – 2023-07-01120847000 USD20240806Open filing evidence
2023-01-01 – 2023-07-01224825000 USD20240806Open filing evidence
2023-01-01 – 2023-04-01103978000 USD20240507Open filing evidence